Shopping Cart
Remove All
Your shopping cart is currently empty
NB512 (compound 39a) is a dual inhibitor targeting both BET and HDAC, exhibiting high affinity for the BRD4 bromodomain and HDAC1/2, with EC50 values ranging from 100 to 400 nM. It demonstrates antiproliferative activity in cancer cell lines PaTu8988T and NMC.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | NB512 (compound 39a) is a dual inhibitor targeting both BET and HDAC, exhibiting high affinity for the BRD4 bromodomain and HDAC1/2, with EC50 values ranging from 100 to 400 nM. It demonstrates antiproliferative activity in cancer cell lines PaTu8988T and NMC. |
| Targets&IC50 | BRD4 BD2:0.25 μM (EC50), HDAC2:0.1 μM (EC50), HDAC1:0.11 μM (EC50), BRD4 BD1:0.36 μM (EC50), HDAC3:13.6 μM (EC50) |
| In vitro | NB512 at a concentration of 1 μM inhibits histone H3 K9/K14 deacetylation and increases the expression of BET target marker HEXIM1 and cell cycle regulatory gene p57 in a dose-dependent manner in PaTu8988T cells. This compound exhibits antiproliferative activity in PaTu8988T and NMC cells, with IC50 values of 3.6 and 0.42 μM, respectively. Additionally, NB512 at 1 μM reduces the expression of oncogenic transcription factors MYC and TP63 in NMC cells. |
| Formula | C26H21N5O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.